Concepedia

Elena Garralda

EG

Statistics

Publications

92

Citations

7.3K

H-Index

39

Active since

1986

Affiliations

Vall d'Hebron Institute of Oncology(Current)

Vall d'Hebron Hospital Universitari

The University of Texas MD Anderson Cancer Center

Seoul National University Hospital

Institut Gustave Roussy

Elena Garralda is an author at Vall d'Hebron Institute of Oncology specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1986–2025

92

Publications

92

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata et al. · Journal of Hepatology · 2013 · 977 citations

, , +12

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 810 citations · Full text

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

Justin F. Gainor, Giuseppe Curigliano, Dong‐Wan Kim et al. · The Lancet Oncology · 2021 · 428 citations · Full text

Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers

Vivek Subbiah, Justin F. Gainor, Rami Rahal et al. · Cancer Discovery · 2018 · 386 citations

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

Vivek Subbiah, Mimi I. Hu, Lori J. Wirth et al. · The Lancet Diabetes & Endocrinology · 2021 · 330 citations

, , +8

1–5 of 92